Tempus AI is a healthcare technology company that uses AI and genomic sequencing to power precision medicine, with its strongest focus in oncology and growing work in cardiology and radiology. It processes multimodal health data through artificial intelligence to deliver real-time, actionable insights to physicians for personalized patient care. Key features include comprehensive genomic profiling and NGS diagnostics (its xT/xR assays), clinical trial matching based on molecular and clinical data with rapid trial-site activation in under two weeks, a clinical application called Hub that surfaces guideline-matched therapies and biomarker tracking at the point of care, and a multimodal data library licensed to researchers and pharmaceutical companies. It’s built for large hospital systems, oncologists, and research institutions rather than individual consumers. Diagnostic tests and data products are billed per-test or through enterprise licensing agreements, negotiated directly with health systems, labs, or pharma partners.
Leave a Reply